Sign in to continue:

Saturday, April 4th, 2026
Stock Profile: NURO
NURO Logo

NeuroMetrix, Inc. (NURO)

Market: NMS | Currency: USD

Address: 4B Gill Street

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, Show more




📈 NeuroMetrix, Inc. Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for NeuroMetrix, Inc.


DateReported EPS
2020-01-28-16.6
2019-10-17-11.2
2019-07-18-9.39
2019-04-2512
2019-01-24-15.84
2018-10-176.4
2018-02-081.6
2017-10-20-248.8
2017-07-20-199.2
2017-04-20-582.4
2017-01-26-332.8
2016-10-20-486.4
2016-07-21-3436.8
2016-02-12-2501.15
2015-10-22-665.6
2013-02-19-2278.4
2012-10-25-3225.6
2012-07-26-3379.2
2012-04-24-5068.8
2012-02-15-9676.8
2011-10-27-9676.8
2011-07-28-10137.61
2011-02-03-16588.81
2010-11-09-13824.01
2010-08-10-18432.01




📰 Related News & Research


No related articles found for "neurometrix inc".